LONDON - BlackRock (NYSE:BLK), Inc., the multinational investment management corporation, has disclosed a significant stake in Dalata Hotel Group plc, a leading hotel operator in Ireland. According to a regulatory filing with the Irish Takeover Panel on March 21, 2025, BlackRock now owns and controls 5,214,066 shares, representing approximately 2.46% of Dalata’s issued share capital.
In addition to the shares, BlackRock holds cash-settled derivatives amounting to 1,328,054 shares, which corresponds to a 0.62% economic interest in the company. The total combined holding of shares and financial derivatives gives BlackRock an aggregate interest of 3.08% in Dalata Hotel Group.
The disclosure was made in accordance with the rules governing the reporting of interests in relevant securities during takeover bids under the Irish Takeover Panel Act, 1997, and Takeover Rules, 2022. The date of the position held by BlackRock was reported as of March 20, 2025, one day prior to the disclosure.
Dalata Hotel Group, which operates hotels primarily in Ireland and the United Kingdom (TADAWUL:4280), has not been subject to any recent takeover announcements, and BlackRock has not reported any dealings in other parties related to the offer. The filing also included a transfer in of 5,180 shares, although the details of this transaction were not specified in terms of price or initiating party.
Investors and market watchers often monitor such disclosures closely, as they can provide insights into the strategies of institutional investors like BlackRock. The filing did not indicate any further intentions regarding BlackRock’s investment in Dalata Hotel Group, nor did it suggest any immediate actions that might affect the hotel operator’s share price or corporate governance.
The disclosure of BlackRock’s stake in Dalata Hotel Group is based on a press release statement and provides a snapshot of the investment manager’s interests in the company as required by regulatory guidelines. The news service of the London Stock Exchange (LON:LSEG), RNS, approved by the Financial Conduct Authority, provided the information.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.